Rapid Dose Therapeutics Corp
OTC:RDTCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rapid Dose Therapeutics Corp
OTC:RDTCF
|
CA |
|
P
|
Phatra Leasing PCL
SET:PL
|
TH |
Intrinsic Value
The intrinsic value of Rapid Dose Therapeutics Corp (RDTCF) under the Base Case is 0.0274 USD per share. Compared with the current market price of 0.0706 USD, the stock appears Overvalued by 61% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Rapid Dose Therapeutics Does
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company, which engages in providing innovative, proprietary, and drug-delivery technologies designed to improve outcomes and quality of lives. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The company provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered…
- Headquarters
- Canada CA
- IPO date
- Dec 17, 2018
Earnings Waterfall
Rapid Dose Therapeutics Corp
The intrinsic value for Rapid Dose Therapeutics Corp (RDTCF) under the Base Case is 0.0274 USD.
Compared with the current market price of 0.0706 USD, the stock appears Overvalued by 61% .